Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ONDS vs GSK✓SelectedUSD · GSKONDS vs GSK performance historyLatest closeAs of-11.11%11/20
Stock and ETF performance explorer

ONDS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+232.7%
GSK return
+53.4%
Excess return
+179.4%
Maximum drawdown
-75.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-11.1%-0.1%-11.0%-11.1%
7D-27.1%-5.3%-21.8%-27.8%
30D-40.0%-3.7%-36.4%-40.3%
3M-55.1%-7.3%-47.9%-55.5%
6M-59.8%-4.2%-55.6%-59.8%
YTD-61.5%+0.9%-62.3%-61.1%
1Y-40.0%+7.3%-47.3%-39.3%
3Y+232.7%+52.7%+180.0%+236.8%
All+232.7%+53.4%+179.4%+236.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling